Aizen Therapeutics

Private

San Diego, CaliforniaHealthcare & Life Scienceshttps://www.aizentx.com/

Last Round

Seed

Nov 21, 2024

Total Funding Raised

$13M

Company Overview

Aizen Therapeutics is a biotechnology company that develops AI-driven mirror peptide therapeutics for the treatment of chronic immune disorders and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoverygenerative AIbiotechnologymirror peptidesAI drug discoveryprotein designD-amino acidsbiologicsin silico drug designtherapeutic developmentde novo designcomputational biologypeptide therapeuticsAI biotechdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aizen Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Aizen Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aizen Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 21, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Ajay Kshatriya

Chief Executive Officer

Executive Team

Aizen Therapeutics Investors

Notable investors and investment history

Aizen Therapeutics investors
Investor	Rounds
Cercano Management	Seed
Madrona Venture Group	Seed
Wilson Hill Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 21, 2024
$13M round led by Madrona Venture Group

View all signals

Aizen Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Aizen Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aizen Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California

Employee Range15

Year Founded2022

Last FundingNov 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.